These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8697478)

  • 21. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 22. [Angiotensin-converting enzyme inhibitors. Principles and rules of their use].
    Juillière Y
    Rev Prat; 2001 Sep; 51(14):1601-7. PubMed ID: 11757278
    [No Abstract]   [Full Text] [Related]  

  • 23. [Angiotensin-converting enzyme inhibitors and ischemic heart disease].
    Ertl G; Kochsiek K
    Dtsch Med Wochenschr; 1989 Apr; 114(14):556-60. PubMed ID: 2649347
    [No Abstract]   [Full Text] [Related]  

  • 24. Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials.
    Pepine CJ
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-58-64. PubMed ID: 9422854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action?
    Rutherford JD
    Trans Am Clin Climatol Assoc; 1996; 107():57-66; discussion 66-7. PubMed ID: 8725560
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
    Healey JS; Morillo CA; Connolly SJ
    Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.
    Pfeffer JM; Fischer TA; Pfeffer MA
    Annu Rev Physiol; 1995; 57():805-26. PubMed ID: 7778884
    [No Abstract]   [Full Text] [Related]  

  • 28. The renin-angiotensin-aldosterone system and cardiac ischaemia.
    Ikram H
    Heart; 1996 Nov; 76(3 Suppl 3):60-7. PubMed ID: 8983666
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anti-atherosclerotic action of ACE inhibitors. I. Inactivation of the renin-angiotensin system].
    Stajszczyk M; Gmiński J
    Postepy Hig Med Dosw; 1996; 50(2):157-71. PubMed ID: 8848424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM; Kamper AL
    Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract]   [Full Text] [Related]  

  • 31. Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view.
    Alderman MH
    Heart; 1996 Nov; 76(3 Suppl 3):18-22. PubMed ID: 8977361
    [No Abstract]   [Full Text] [Related]  

  • 32. [Angiotensin-converting enzyme inhibitors. Principles and rules of use].
    Eicher JC; Wolf JE
    Rev Prat; 1998 Apr; 48(7):771-6. PubMed ID: 11767373
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of the cardiac renin-angiotensin system on hypertrophy].
    Ertl G; Schorb W; Gaudron P; Hu K
    Z Kardiol; 1996; 85 Suppl 6():233-40. PubMed ID: 9064970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
    Pichler M; Klein W; Huber K; Pachinger O
    Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug differences between ACE inhibitors in experimental settings and clinical practice.
    Voors AA; Kingma JH; van Gilst WH
    J Cardiovasc Risk; 1995 Oct; 2(5):413-22. PubMed ID: 8749268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular protection of ACE inhibitors.
    Messerli FH
    Arch Intern Med; 2003 Dec 8-22; 163(22):2791-2; author reply 2792-3. PubMed ID: 14662639
    [No Abstract]   [Full Text] [Related]  

  • 37. Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
    Jacoby DS; Rader DJ
    Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pragmatic approach to the use of angiotensin-converting enzyme inhibitors in acute myocardial infarction.
    Vantrimpont P; Rouleau JL
    Can J Cardiol; 1996 Oct; 12(10):924-9. PubMed ID: 9191482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renin-angiotensin system modulation: instructions for use].
    Bellis A; Rozza F; Crispo S; Trimarco B
    G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is a combination of verapamil and an ACE-inhibitor the optimal solution in ischaemic heart failure?
    Jespersen CM
    Cardiologia; 1995 Dec; 40(12 Suppl 1):307-10. PubMed ID: 8903054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.